“About a quarter of people who ordered direct-to-consumer genetic testing from companies like 23andMe reported discussing the results with their primary care doctors. But nearly one in five were not at all satisfied with the conversations, researchers report”
With the passing of the Genetic Information Nondiscrimination Act, the federal government has barred health insurance companies from denying coverage for those who have a genetic mutation. However, it does not cross over into private insurance companies, which can ask about genetic history and information.
Within the REVEAL-SCAN study, one group of participants are given back the results on Alzheimer’s and additional heart disease information. Patients who are receiving the additional information are finding it reassuring that they can take measures to prevent at least one of their possible conditions if they have mutations for both.